Thus, our further work will examine whether pharmacological inhibition of Dll4 could attenuate catecholamine release, thereby reducing the incidence of neurogenic pulmonary edema in children with severe HFMD. This evidence concerns the gene DLL4 and hand, foot and mouth disease.